000			02113 a2200625 4500
005			20250517124756.0
264		0	_c20180112
008			201801s 0 0 eng d
022			_a1029-2403
024	7		_a10.1080/10428194.2016.1256481 _2doi
040			_aNLM _beng _cNLM
100	1		_aBartlett, Nancy L
245	0	0	_aBrentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry. _h[electronic resource]
260			_bLeukemia & lymphoma _c07 2017
300			_a1607-1616 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents, Immunological _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBiomarkers
650	0	4	_aBrentuximab Vedotin
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoconjugates _xadministration & dosage
650	0	4	_aImmunohistochemistry
650	0	4	_aKi-1 Antigen _xmetabolism
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aRecurrence
650	0	4	_aRetreatment
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aSmith, Mitchell R
700	1		_aSiddiqi, Tanya
700	1		_aAdvani, Ranjana H
700	1		_aO'Connor, Owen A
700	1		_aSharman, Jeff P
700	1		_aFeldman, Tatyana
700	1		_aSavage, Kerry J
700	1		_aShustov, Andrei R
700	1		_aDiefenbach, Catherine S
700	1		_aOki, Yasuhiro
700	1		_aPalanca-Wessels, Maria Corinna
700	1		_aUttarwar, Mayur
700	1		_aLi, Martha
700	1		_aYang, Jing
700	1		_aJacobsen, Eric D
773	0		_tLeukemia & lymphoma _gvol. 58 _gno. 7 _gp. 1607-1616
856	4	0	_uhttps://doi.org/10.1080/10428194.2016.1256481 _zAvailable from publisher's website
999			_c26623996 _d26623996